Latanoprostene Bunod
Brand name: Vyzulta
Rank #284 of 500 drugs by total cost
Data: CMS Medicare Part D, 2023 (most current available) · Updated March 2026
$41.6M
Total Cost
92,705
Total Claims
$41.6M
Total Cost
2,181
Prescribers
$449
Cost per Claim
18,521
Beneficiaries
138,837
30-Day Fills
$19K
Avg Cost/Provider
43
Avg Claims/Provider
Share of Medicare Part D Spending
0.02%
of total Medicare Part D spending
$41.6M of $275.65B
Top Prescribers by Cost
Top 10 prescribers of $41.6M total
Top Prescribers of Latanoprostene Bunod
| # | Provider | Specialty | Location | Claims | Cost |
|---|---|---|---|---|---|
| 1 | David Mora | Optometry | Laredo, TX | 1,068 | $553K |
| 2 | Edward Braunstein | Ophthalmology | New York, NY | 1,104 | $395K |
| 3 | Ilona Genis | Ophthalmology | Brooklyn, NY | 613 | $257K |
| 4 | Alexander Zabaneh | Ophthalmology | Chula Vista, CA | 474 | $225K |
| 5 | Tae Kim | Ophthalmology | Cerritos, CA | 544 | $209K |
| 6 | Andrew Cho | Ophthalmology | Los Angeles, CA | 454 | $191K |
| 7 | Charles Niles | Ophthalmology | Williamsville, NY | 389 | $190K |
| 8 | Irina Pankova | Ophthalmology | Brooklyn, NY | 377 | $171K |
| 9 | David Sola-Del Valle | Ophthalmology | Danville, IL | 282 | $164K |
| 10 | Jacqueline Gabay | Ophthalmology | Elmwood Park, NJ | 331 | $162K |
| 11 | Jon Portis | Ophthalmology | Honolulu, HI | 276 | $160K |
| 12 | Jerry Shuster | Ophthalmology | Maitland, FL | 320 | $157K |
| 13 | Scott Schecter | Optometry | Fort Lauderdale, FL | 462 | $153K |
| 14 | Carl Sloan | Ophthalmology | Myrtle Beach, SC | 214 | $152K |
| 15 | Rebecca Bobo | Ophthalmology | Stuart, FL | 456 | $149K |
Top prescribers ranked by total cost for this drug in 2023.
Related Drugs by Cost
| # | Drug | Total Cost | Claims |
|---|---|---|---|
| 281 | Hydrochlorothiazide (Hydrochlorothiazide) | $42.4M | 7,879,021 |
| 282 | Tadalafil (Tadalafil) | $42.3M | 91,082 |
| 283 | Topiramate (Topiramate) | $41.9M | 1,141,093 |
| 284 | Latanoprostene Bunod (Vyzulta) | $41.6M | 92,705 |
| 285 | Travoprost (Travoprost) | $41.5M | 178,599 |
| 286 | Alendronate Sodium (Alendronate Sodium) | $41.4M | 3,414,824 |
| 287 | Daptomycin (Daptomycin) | $41.2M | 41,245 |
Related Analysis
Data from CMS Medicare Part D Prescriber-Drug Public Use File, 2023. Methodology